Cardiovascular autonomic function (CVAF) is an important aspect of cardiovascular health. Variables reflecting this, such as heart rate variability (HRV) and baroreflex sensitivity (BRS), predict risk of cardiovascular events. [1] [2] [3] Impaired autonomic function has been identified as a factor in the pathogenesis of hypertension. In support of this, both parasympathetic and sympathetic activity have physiological effects on blood pressure (BP) 4 and low HRV is associated with greater risk of incident hypertension. 5 Further, impaired HRV predicts new-onset atrial fibrillation, 6 which is associated with an increased risk of cardiovascular morbidity and mortality. 7, 8 Identifying determinants of CVAF is thus useful for understanding how factors may impact on cardiovascular health.
measures would be attained by carrying out subgroup analyses in different regions of the HRV distribution.
Another gap in prior research is knowledge of whether CVAF varies with Polynesian and South Asian ethnicities. This is significant as these ethnic groups have a higher prevalence of cardiovascular disease relative to European (White) populations. 15, 16 Further, previous studies have evaluated relationships of CVAF with brachial BP but not with other arterially related parameters. These include augmentation index, peak reservoir pressure, and excess pressure integral; parameters which may predict cardiovascular burden independently of brachial BP. [17] [18] [19] We sought to examine how CVAF parameters vary with demographic and clinical factors. To build on past research, these associations were evaluated across various percentiles of the distribution of these CVAF measures, we included participants of Polynesian (Maori and Pacific) and South Asian ethnicity, and measurements taken from the aortic pressure waveform were included in analyses.
METHODS

Participants
The present study is an analysis of baseline data collected in the ViDA (Vitamin D Assessment) study, a randomized controlled trial of the health effects of vitamin D supplementation. Inclusion criteria were men and women aged 50-84 years and resident in Auckland at recruitment. Exclusion criteria included (i) diagnosis of a terminal illness and/or in hospice care; (ii) intending to leave New Zealand during the follow-up period; (iii) taking vitamin D supplements (including cod liver oil) of >600 IU per day; (iv) history of renal stones, hypercalcemia, or medical conditions that can cause hypercalcemia; and (v) baseline serum calcium >2.50 mmol/l. All baseline data were collected between 2011 and 2012. Ethics approval was provided by the Ministry of Health Multi-region Ethics committee. Written informed consent was obtained from each participant. Full details of the study design have been published elsewhere. 20 
Demographic and non-BP, clinical variables
All measurements were carried out by trained staff using a standardized protocol. Questionnaires administered by interviewers were used to collect data on age, sex, ethnicity (defined by self-identification), and history of diabetes. Past diagnosis of a cardiac arrhythmia was also determined from these questionnaires and from Ministry of Health hospitalization data; since HRV assessment is traditionally applied to people without a cardiac arrhythmia. Without shoes and in light clothing, height (±0.1 cm) was measured with a stadiometer and weight (±0.1 kg) with digital scales. BMI was calculated as weight (kg)/height (m 2 ).
To adjust for the effect of antihypertensive medications on the CVAF parameters, prescriptions dispensed for days of supply that encompassed the interview date were recorded from Ministry of Health data. Antihypertensive medicines were categorized into beta-blockers and non-beta-blockers since these drug classes may differentially affect CVAF parameters. 21, 22 
BP variables
After 15 minutes resting and while sitting, brachial BP (±1 mm Hg) was measured 3 times with an Omron T9P oscillometric device (Omron Healthcare, Kyoto, Japan) above the cubital fossa of the left arm and the mean of the 2 closest measurements was used for analyses. Suprasystolic oscillometry was carried out using a BP+ device (Uscom, Sydney, Australia) (formerly known as a R6.5 cardiovascular monitor; Pulsecor, Auckland, New Zealand), with an appropriately-sized cuff positioned over the left upper arm. The BP+ device has been shown to: (i) yield central systolic BPs that are highly correlated with those assessed by catheter measurement at the ascending aorta or aortic arch 23 and (ii) measure central systolic BP with good intratest and intertest reliability. 24 To improve the quality of the waveforms used in analyses, we decided a priori to exclude readings with a signal-to-noise ratio of <6 dB.
Augmentation index, a predictor of CV events, 17 was calculated from the aortic pressure waveform using customwritten Matlab software (Mathworks, Natick, MA). Aortic pressure was separated into reservoir and wave components using custom-written Matlab software. Reservoir pressure was calculated from pressure measurements only, as described elsewhere. 18 Peak reservoir pressure was calculated as the amplitude of the reservoir pressure waveform, which has been found to associate positively with the risk of cardiovascular events independently of brachial BP. 19 Excess pressure was calculated as measured aortic pressure minus reservoir pressure. 19 The integral of the excess pressure waveforms (area under these waveforms) over the cardiac cycle was used to calculate excess pressure integral. Excess pressure integral measures pressure associated with excess ventricular work and has been shown to predict CV events independently of brachial SBP. 18 
CVAF measures
Pulse rate variability was assessed from the variability of the beat duration of the aortic pressure waveforms derived from the BP+ device. The waveforms spanned approximately 10 seconds; thus, analysis was performed on approximately 10 to 12 pulse intervals (PIs), a period adequate for valid measurement of HRV. [25] [26] [27] [28] [29] Two time-domain measures were used: root mean square of successive differences (RMSSD) and SD of PIs (in ms; analogous to SD of NN intervals of an electrocardiographic record). 30 RMSSD (in ms) was calculated as the square root of the mean of the squared differences of the duration of successive PIs and reflects parasympathetic activity. 30 BRS was assessed using the sequence method, which establishes the slope of the relationship between changes in PI and SBP across successive cardiac cycles. 31, 32 PIs were paired with the SBP (maximum amplitude of the pressure waveform) of the preceding cardiac cycle (that is, a one-beat delay), as described elsewhere. 31, 32 Instances in which SBP and PIs both increased (+PI/+SBP) or decreased (−PI/−SBP) from one beat to the next were detected. Due to the limited number of beats, we did not enforce the practice 31 that these changes had to occur over at least 3 consecutive beats. The minimum SBP change between PIs that was accepted was 1 mm Hg. BRS (in ms/mm Hg) was calculated as the mean of all +PI/+SBP and −PI/−SBP slopes.
Statistical analysis
All analyses were performed using SAS version 9.3 (SAS Institute, Cary, NC). Because of the influence of cardiac arrhythmias on pulse rate variability, analyses were restricted to participants without previously diagnosed cardiac arrhythmia. In a subgroup analysis of this sample, we performed a supplementary set of analyses excluding people with an RMSSD of >100 ms as these values may be indicative of unknown cases of atrial fibrillation. 33 Factors that were associated with CVAF variables were identified by multiple ordinary linear regression and quantile regression. The latter is a statistical approach that examines predictors of different percentiles of a response variable. While ordinary linear regression models only the mean of a dependent variable, quantile regression can model any part of the distribution of it, thus giving more comprehensive results. 34 For this technique, we assessed relationships in 19 percentile groups (5 percentiles apart) ranging from the 5 th to the 95 th percentile (that is, the 5 th , 10 th , 15 th , … , 90 th , and 95 th percentiles). Linearity of these associations was checked in each percentile group of the response (CVAF) variable. To evaluate whether the regression coefficients varied across the quantiles, we used the qinteract option in PROC QUANTREG. We compared quantile regression results with those from ordinary linear regression; this approach has been applied in other studies that utilize quantile regression 34 and allows a comparison with other HRV studies that use ordinary linear regression. These multivariable relationships were adjusted for age, sex, ethnicity, and use of antihypertensive medicines (none, non-beta-blockers, or beta-blockers). A 2-tailed P <0.05 was considered statistically significant. Table 1 shows the characteristics of the participants, which comprised 4,167 people. Figures 1-3 show differences in CVAF measures (Figure 1 for RMSSD, Figure 2 for SD PIs, and Figure 3 for BRS) per unit difference (or across groups for categorical variables) in demographic/clinical factors by percentile of the CVAF measure. Table 2 lists these effect sizes for selected percentiles (10 th and 90 th ) and tabulates effect sizes estimated by ordinary linear regression. Age was inversely related to both RMSSD up to the 60 th percentile of this parameter and SD of PIs up to the 45 th percentile. But at higher percentiles, the age coefficients markedly increased, becoming positive (both P <0.0001 for trend). Compared to females, males had lower RMSSD and SD of PIs at lowmiddle percentiles (≤60 th ) of these parameters but higher levels at high percentiles (P = 0.0006 and 0.03, respectively). Relative to Europeans, Pacific people had higher RMSSD at upper percentiles of this parameter and lower SD of PIs at low percentiles. Maori ethnicity was associated with higher RMSSD and SD of PIs at high percentiles especially. South Asian ethnicity was unrelated to the 3 CVAF parameters. Brachial SBP, brachial DBP, and peak reservoir BP had inverse relationships with BRS that were greater at higher percentiles, with the maximum quantile-specific slope increase being nearly 10-fold in each case (P < 0.0001, P = 0.001, and P = 0.002, respectively, for trends). Augmentation index was positively associated with all 3 CVAF variables (at most or all quantiles) but especially so at higher quantiles (all P < 0.0001); the greatest increase in coefficients was about 11, 12, and 10 times for RMSSD, SD of PIs, and BRS, respectively. Excess pressure integral was positively associated with BRS between the 75 th and 85 th percentiles only (P = 0.01 for trend across all quantiles). BMI was unrelated to SD of PIs at low levels of this CVAF parameter but had increasingly positive associations at higher percentiles. Conversely, BMI had increasingly inverse relationships with BRS at higher percentiles of this CVAF measure (maximum slope difference = 13-fold; P = 0.004). Diabetes was associated with a lower RMSSD up to the 65 th percentile of the latter and SD of PIs up to the 30 th percentile. Compared to percentilespecific coefficients determined from quantile regression (Figures 1-3 ), regression coefficients estimated by ordinary linear regression (Table 2 ) noticeably differed in magnitude often (by >3 times in several cases) and differed in direction sometimes.
RESULTS
In a subgroup analysis of this sample, we excluded people (n = 385) with an RMSSD of >100 ms, which may be indicative of unknown cases of atrial fibrillation, and repeated the ordinary linear and quantile regression analyses (Supplementary Table S1 , Supplementary Figures S1-S3 ). As shown in these results, for RMSSD and SD of PIs, the slopes at high percentiles of these parameters generally deviated less from those at lower percentiles. Age was still inversely related to RMSSD at lower percentiles of this parameter but now even more so at higher quantiles (P = 0.002), with the greatest slope increase being by a factor of nearly 3. Male sex was still associated with lower RMSSD and SD of PIs at low quantiles but now increasingly so (up to 6-and 11-fold slope differences, respectively) at higher quantiles (P = 0.005 and 0.02, respectively, for overall trends). For BRS, the quantileplot trends were similar in the subgroup analysis sample (Supplementary Figures S1-S3 ) compared to in the total sample (Figures 1-3) .
DISCUSSION
This study showed that, among people without cardiac arrhythmias, age, sex, Pacific and Maori ethnicity, BP variables, BMI, and diabetes were associated with CVAF parameters. But, in many cases, these associations varied along the distributions of CVAF measures, becoming stronger at higher percentiles and sometimes changing direction.
In several cases, slopes for each percentile were noticeably different from those obtained from ordinary linear regression. For instance, we reported that, across percentiles, slopes increased by up to more than 10-fold and even changed direction in some cases (Table 2 and horizontal lines in Figures 1-3) . This indicates that, rather than reliance on ordinary linear regression, quantile regression provides a more comprehensive assessment of factors associated with CVAF.
Ordinary linear regression relies on meeting assumptions of linearity of associations and both homoscedasticity and normality of regression residuals. Because our observed relationships differed by levels of the HRV outcome, ordinary linear regression would be invalid or inadequate by violating these assumptions. The importance of this problem to HRV studies is increased by the finding that these assumptions are often not tested prior to presenting results of linear regression. 35 In contrast, quantile regression does not need assumptions about the distribution of the residuals and is not influenced by outliers or skewness in the distribution of the response variable. [36] [37] [38] Thus, in addition to being more informative than ordinary linear regression for studying HRV, quantile regression is a more adequate or valid statistical method.
At low percentiles of RMSSD and SD PIs, these response variables were inversely associated with age (which concurs with previous HRV studies 10 ) and were lower in males. However, these relationships were positive at higher percentiles (Table 2 ; Figures 1 and 2) . Given that cardiovascular disease/events correlate positively with HRV parameters at high levels of these measures 3,13 but inversely at lower levels, 1, 3, 5 this suggests that these age-and sex-related variations in pulse rate variability parameters may contribute to the increased risk of cardiovascular disease observed among older people and males.
Polynesian and South Asian people experience greater cardiovascular disease morbidity compared to White populations. 15, 16 Given that CVAF measures predict cardiovascular events, 1-3 ethnic differences in these parameters might contribute to this discrepancy in cardiovascular disease burden. However, there is a lack of knowledge about whether these measures vary between these ethnic groups. In this study, these parameters did not vary between South Asian and European groups, suggesting that they might not mediate differences in cardiovascular burden between these populations. In contrast, relative to Europeans, Maori people had higher RMSSD and SD of PIs at high percentiles of these parameters, while Pacific people had higher RMSSD at high percentiles and lower SD of PIs at low percentiles (Table 2 ; Figures 1 and 2) . Thus, these differences could contribute to the higher cardiovascular disease burden observed in Polynesian populations.
Age and BMI both associate inversely with BRS. 11 The present study extends this prior research by showing that the sizes of these relationships vary across the BRS distribution ( Figure 3 ). In addition, while previous studies have shown that BRS decreases with brachial SBP, 11 which is supported by the present study, our findings also show that its relationships with brachial SBP, brachial DBP, and peak reservoir BP are increasingly inverse at higher BRS percentiles (Figure 3) . We further add to this past work by demonstrating that augmentation index is positively related to BRS at high percentiles of the latter but not at low percentiles ( Figure 3) .
As for limitations of this study, the observational design (cross-sectional) precludes causal inferences. The CVAF measures were collected over typically 10-12 seconds and, while several studies demonstrate that time-domain measures (especially RMSSD) calculated from 10-second recordings reliably estimate HRV, a longer sampling interval (typically 5-minutes) is preferable. [25] [26] [27] [28] [29] Nevertheless, our results are consistent with those of previous studies that investigated correlates of parameters from ≥5-minute HRV recordings, which supports the validity of our HRV measures. For instance, in line with prior research, our results (Table 2 ; Figures 1 and 3) showed that, at most percentiles, RMSSD decreased with age 10 and was lower among diabetics, 12 while BRS decreased with age, brachial BP, and BMI. 11 In summary, we observed that age, sex, Pacific and Maori ethnicity, BP variables, BMI, and diabetes were related to CVAF measures but these associations varied across CVAF percentiles. The quantile dependency of these relationships could account, at least in part, for the skewed distributions All models were adjusted for age, sex ethnicity and antihypertensive use. Abbreviations: BMI, body mass index; BP, blood pressure; DBP, diastolic BP; EPI, excess pressure integral; OLR, ordinary linear regression; RMSSD, root mean square of successive differences; SBP, systolic BP.
a Reference groups for ethnicity and male sex variables are "European" and "female," respectively. 95% Confidence intervals that do not encompass zero are in bold.
observed with CVAF measures. In addition, they highlight the importance of quantile regression in examining these associations and that prior studies which relied on ordinary linear regression are likely to have not captured these variations by percentile.
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